Results

Halozyme Therapeutics Inc.

02/24/2021 | Press release | Distributed by Public on 02/24/2021 21:45

Halozyme Therapeutics, Inc. Announces Pricing of Private Offering of $700 Million of Convertible Senior Notes due 2027